Recent Updates
Recently added Catalysts
IPHA Positive Sentiment

Innate Pharma to Participate in the Stifel Healthcare Conference and Jefferies Global Healthcare Conference

Key Takeaway: Innate Pharma announced its participation in the upcoming Stifel Healthcare Conference and Jefferies Global Healthcare Conference. This involvement could provide valuable exposure and networking opportunities for the company. The events are significant in the healthcare sector, potentially benefiting Innate Pharma's strategic goals.

Market Sentiment Analysis

POSITIVE FACTORS

  • Innate Pharma is actively participating in key healthcare conferences.
  • The participation may enhance visibility and networking opportunities.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+35%
120-day peak, hindsight
Typical move
7.6%
average across 4 past catalysts
Lead asset
IPH5201
Phase 2 · Non Small Cell Lung Cancer

Full Press Release Details

MARSEILLE, France--(BUSINESS WIRE)-- #Biotech--Innate Pharma to participate in the Stifel Healthcare Conference and Jefferies Global Healthcare Conference

Frequently Asked Questions

What conferences will Innate Pharma attend?

Innate Pharma will attend the Stifel Healthcare Conference and Jefferies Global Healthcare Conference.

Why is Innate Pharma participating in these conferences?

The participation aims to enhance visibility and networking opportunities.

Where is Innate Pharma based?

Innate Pharma is based in Marseille, France.

What is the significance of these conferences?

These conferences are significant for networking in the healthcare sector.

Last updated: Oct 21, 2026